💉Monitoring blood tests for patients on DMARDs?
Researchers at @manchesteruni & @UniofNottingham want to learn more about #DMARD monitoring practices across the UK.
Please take the survey to help inform future guidance & safer care: https://t.co/4dLE7pNpBH
@KearsleyFleet
📢New blog: With the development of our updated b/tsDMARDS guideline well underway, hear from members of the guideline working group to discover the new evidence the updated guideline will incorporate.
Access the scope now: https://t.co/672vVKtuFV
A bombshell metaanalysis just landed in @AGA_CGH : Advanced therpies work better in colonic #Crohn vs. Ileal dis 😱
aTNFs/aIL23-aIL12/23 were all more effective in the colon, aIntegrin same efficacy in both(?), and JAKi were ONLY EFFECTIVE IN COLON....
https://t.co/fuuo1GExEv
Effectiveness of pharmacological therapies for adults with #fibromyalgia (overview of Cochrane Reviews)
◦#Duloxetine, milnacipran, and #pregabalin showed substantial pain relief in about 1 in 10 adults; pain benefits were not associated with other symptom benefits for these three drugs in the Cochrane reviews.
◦ Reviews could not inform which adults might benefit or experience adverse events.
◦ Most reviews found no trials (carbamazepine, clonazepam, lamotrigine, phenytoin, oxycodone, topiramate, or valproate) or only low-quality evidence subject to bias (antipsychotics, cannabinoids, combination therapy, gabapentin, lacosamide, monoamine oxidase inhibitors, NSAIDs, amitriptyline, selective serotonin reuptake inhibitors).
*Moore A, Bidonde J, Fisher E, et al. Effectiveness of pharmacological therapies for fibromyalgia syndrome in adults: an overview of Cochrane Reviews. Rheumatology (Oxford). 2025;64(5):2385-2394.
🔗https://t.co/fr9ekruGQi
NHS trusts in England have started taking the first steps towards a dedicated pharmacy service for emergency departments, but as @AliJaneMoore discovered, there is a long way to go before each trust has the recommended support in place
https://t.co/vuMaHPYHGG
🏥 Your MDT’s input matters! Understanding how #biologics & #tsDMARDs are used in #JIA treatment will help improve care and guide NHS updates.
Please share your thoughts by 15 April 2025: https://t.co/vC2Pv5vmH4
🔥 Herbal Supplements that Make Lupus Worse!
https://t.co/U63rFncYtv
A recent study evaluated herbal supplement intake in 673 patients who had #lupus#SLE or #dermatomyositis
The following herbs caused lupus flares so avoid these:
👉Elderberry
👉Ashwagandha
👉Echinacea
👉Spirulina
👉Alfalfa
👉Chlorella
Fewer patients took the following. But as a group, 17% of lupus patients flared:
- moringa
- Zyflamend (blend of 10 herbs)
- herbal teas
- green drinks
- immune-system boosting supplements
- protein powders
BOTTOM LINE:
Avoid supplements that "boost" or "support" the immune system.
The lupus immune system is already overactive (or boosted), you don't want to boost it more!
Patients taking turmeric (curcumin) did NOT flare. One patient with dermatomyositis got better.
Next paper hoping to win the coveted #FGCup is "Investigation of abnormal LFTs in patients with IBD"
https://t.co/fw4h6now62
None of us are a stranger to deranged LFTs in IBD which is why this review is a much needed and "go to" guide. This structured review tells you much of where to start and when to worry. And if that wasn't enough, there is even a podcast accessed via the below links:
▶️ Apple: https://t.co/REJ5oocaNG
▶️ Spotify: https://t.co/NGCAe1TDqa
▶️ Web: https://t.co/5BamI5F7Kh
@jascott87@ChrisMysko@VSAthwal@sheiybani@OTavabie@dr_aditi_kumar #livertwitter
Irritable bowel syndrome #IBS is a chronic disorder of gut-brain interaction that affects a large portion of the population.
This review highlights non-pharmaceutical treatment options to aid GPs and gastroenterologists in expanding their clinical toolkit
https://t.co/A4eXhKNxTa
Delighted that one of our studies from 2024 was chosen as a finalist for the @VersusArthritis Research highlight of the year award
With joint 1st authors @carlosraul_ram@MaxLyon1
https://t.co/lWEqJsIRIY
Some great projects showcased below. Please do vote! Ours is number 3 ;)
📊 Calling all rheumatology pharmacists! We're using your experiences to help shape the new job planning guidance for rheumatology pharmacists. Focus areas include clinical practice, education, and leadership. You can help by taking the survey: https://t.co/RUXqng403i
Methotrexate and ILD
0.5% pneumonitis - rare!
➡️Usually within first 6-12 months
🔥Inflammatory process NOT fibrotic
Little evidence it causes fibrosis it causes a pneuominitis
ILD likely related to the RA-Disease rather than MXT. Respiratory Colleagues please dont stop my MXT👋
High dose loperamide can be prescribed to reduce stoma output or in short bowel syndrome.
Our updated article discusses licensing, dosing and monitoring of loperamide for these indications.
Check it out, available ⤵️: https://t.co/3Ng2W7xqIg